Skip to main content
T2 Biosystems enters partnership with Cidara
9/7/2017

A partnership was reached by T2 Biosystems and Cidara Therapeutics to support trials for Cidara's echinocandin antifungal CD101s with the commercial placement of T2Dx instruments. The program will allow preferred sales terms to be offered by T2 to US trial sites, and reimbursement coverage to be provided by Cidara to centers that adopt T2Candida tests for patient enrollment.

Full Story: